Skip to main content

Table 2 The calculated concentrations for each HER-2-positive real sample using the proposed method

From: Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform

Sample number

Average ECL intensity

The calculated concentration (nM)

Sample 1

59.725

0.600

Sample 2

125.550

0.140

Sample 3

69.675

0.481

Sample 4

142.375

0.096

Sample 5

207.375

0.023

Sample 6

186.20

0.036

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us